184 related articles for article (PubMed ID: 32713286)
1. Reciprocal Upshot of Nitric Oxide, Endoplasmic Reticulum Stress, and Ubiquitin Proteasome System in Parkinson's Disease Pathology.
Tiwari S; Singh S
Neuroscientist; 2021 Aug; 27(4):340-354. PubMed ID: 32713286
[TBL] [Abstract][Full Text] [Related]
2. UBA52 Is Crucial in HSP90 Ubiquitylation and Neurodegenerative Signaling during Early Phase of Parkinson's Disease.
Tiwari S; Singh A; Gupta P; Singh S
Cells; 2022 Nov; 11(23):. PubMed ID: 36497031
[TBL] [Abstract][Full Text] [Related]
3. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
4. The Role of Ubiquitin-Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease.
Liang Y; Zhong G; Ren M; Sun T; Li Y; Ye M; Ma C; Guo Y; Liu C
Neuromolecular Med; 2023 Dec; 25(4):471-488. PubMed ID: 37698835
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-proteasome system and Parkinson's diseases.
Betarbet R; Sherer TB; Greenamyre JT
Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
[TBL] [Abstract][Full Text] [Related]
6. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
[TBL] [Abstract][Full Text] [Related]
7. S-Nitrosylation at the active site decreases the ubiquitin-conjugating activity of ubiquitin-conjugating enzyme E2 D1 (UBE2D1), an ERAD-associated protein.
Fujikawa K; Nakahara K; Takasugi N; Nishiya T; Ito A; Uchida K; Uehara T
Biochem Biophys Res Commun; 2020 Apr; 524(4):910-915. PubMed ID: 32051088
[TBL] [Abstract][Full Text] [Related]
8. Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease and Dopa-Responsive Dystonia.
Kawahata I; Fukunaga K
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471089
[TBL] [Abstract][Full Text] [Related]
9. Convergent Molecular Pathways in Type 2 Diabetes Mellitus and Parkinson's Disease: Insights into Mechanisms and Pathological Consequences.
Xxxx S; Ahmad MH; Rani L; Mondal AC
Mol Neurobiol; 2022 Jul; 59(7):4466-4487. PubMed ID: 35575870
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes.
Lim KL; Lim TM
IUBMB Life; 2003 Jun; 55(6):315-22. PubMed ID: 12938733
[TBL] [Abstract][Full Text] [Related]
11. A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease.
Cook C; Petrucelli L
Biochim Biophys Acta; 2009 Jul; 1792(7):664-75. PubMed ID: 19419700
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Role of Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease.
Zhao Y; Lin M; Zhai F; Chen J; Jin X
Pharmaceuticals (Basel); 2024 Jun; 17(6):. PubMed ID: 38931449
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein aggregation, Ubiquitin proteasome system impairment, and L-Dopa response in zinc-induced Parkinsonism: resemblance to sporadic Parkinson's disease.
Kumar V; Singh D; Singh BK; Singh S; Mittra N; Jha RR; Patel DK; Singh C
Mol Cell Biochem; 2018 Jul; 444(1-2):149-160. PubMed ID: 29198021
[TBL] [Abstract][Full Text] [Related]
14. Physiological and pathological role of the ubiquitin-proteasome system in the vascular smooth muscle cell.
Demasi M; Laurindo FR
Cardiovasc Res; 2012 Jul; 95(2):183-93. PubMed ID: 22451513
[TBL] [Abstract][Full Text] [Related]
15. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
[TBL] [Abstract][Full Text] [Related]
16. [Pathological mechanisms of Parkinson's disease].
Matsui H; Takahashi R
Brain Nerve; 2009 Apr; 61(4):441-6. PubMed ID: 19378814
[TBL] [Abstract][Full Text] [Related]
17. Heredity in Parkinson's disease: new findings.
Lev N; Melamed E
Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
[TBL] [Abstract][Full Text] [Related]
18. Reductions of the components of the calreticulin/calnexin quality-control system by proteasome inhibitors and their relevance in a rodent model of Parkinson's disease.
Kuang XL; Liu F; Chen H; Li Y; Liu Y; Xiao J; Shan G; Li M; Snider BJ; Qu J; Barger SW; Wu S
J Neurosci Res; 2014 Oct; 92(10):1319-29. PubMed ID: 24860980
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathways and genetic aspects of Parkinson's disease: from bench to bedside.
Di Napoli M; Shah IM; Stewart DA
Expert Rev Neurother; 2007 Dec; 7(12):1693-729. PubMed ID: 18052765
[TBL] [Abstract][Full Text] [Related]
20. Endoplasmic reticulum stress and Parkinson's disease: the role of HRD1 in averting apoptosis in neurodegenerative disease.
Omura T; Kaneko M; Okuma Y; Matsubara K; Nomura Y
Oxid Med Cell Longev; 2013; 2013():239854. PubMed ID: 23710284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
